Investigation & Intelligence Feeds
Akin Intelligence Newsletter – August/September 2025
On October 21, 2025, the Commerce Department’s International Trade Administration (ITA) announced the launch of the American AI Exports...
UK Financial Conduct Authority Consults on Fund Tokenisation
Historically, the FCA’s position on crypto assets was consistently to repeat to consumers that “if you decide to invest in crypto then ...
A Simulcast Sunset on the Horizon as FCC Adopts NextGen TV NPRM
At today’s Open Meeting, the FCC unanimously adopted a Fifth Further Notice of Proposed Rulemaking (NPRM) to accelerate the transition ...
Agentic AI: An Agent of Change in the Ecommerce Space
Artificial intelligence tools designed to perform a specific autonomous function with limited human interaction (commonly referred to a...
California AI Transparency Act Amendments Signed Into Law
California expands the scope of the California AI Transparency Act by adding compliance obligations and extends the operative date to A...
SCOTUS Turns Away Zillow Antitrust Case and Questions About Platform Power
The U.S. Supreme Court has declined to review Real Estate Exchange Inc. v. Zillow Group, Inc. and National Association of Realtors, lea...
Part 2 of The 12-Minute Habit: How Legal Pros Can Make Learning Stick (and Keep Their Sanity)
We covered part 1 of Sheila Grela’s terrific article on Monday. Here’s part 2 of The 12-Minute Habit: How Legal Pros Can Make Learning ...
European Commission Publishes Draft Guidance on Reporting Serious AI Incidents
The draft provides further detail on the reporting obligations under Article 73 of the EU AI Act; companies may submit comments until 7...
The Precedent: Federal Circuit Clarifies that Issuance of an Amended Claim Does Not Provide Substantial Evidence of Compliance with the Written Description Requirement
In this edition of The Precedent, we outline the decision in Mondis Technology Ltd. v. LG Electronics Inc. In Mondis Technology Ltd. v....
ANDA Approvals – Third Quarter 2025
This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applicatio...